| 產品名稱 |
Human adenovirus 7a |
| 商品貨號 |
B163289 |
| Classification |
Adenoviridae, Mastadenovirus, Human adenovirus B |
| Deposited As |
Adenovirus type 7a |
| Agent |
Human adenovirus 7a |
| Strain |
S-1058 |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Presumed from throat swab from case of undifferentiated respiratory infection, Maryland |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Comments |
Agglutinates rat RBC. Not inactivated by ether. Contains group-specific CF antigen. Derivied from V-207A-001-014 |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects in tissue culture CPE, monolayer degeneration CPE in tissue culture |
| Recommended Host |
Recommended Host: KB cells (ATCC? CCL-17™) |
| Growth Conditions |
Atmosphere: 5% CO2 in air recommended Temperature: 37.0°C Duration: 2-3 days |
| Name of Depositor |
NIH/NIAID |
| Source |
Presumed from throat swab from case of undifferentiated respiratory infection, Maryland |
| References |
Rowe WP, et al. Serotype composition of the adenovirus group. Proc. Soc. Exp. Biol. Med. 97: 465-470, 1958. PubMed: 13518306
Hierholzer JC, et al. Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera. Arch. Virol. 121: 179-197, 1991. PubMed: 1759904
Gall J, et al. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 70: 2116-2123, 1996. PubMed: 8642632
|
